The target of rapamycin (TOR) is a highly conserved Ser/Thr kinase that plays a central role in the control of cellular growth. TOR has a characteristic multidomain structure. Only the kinase domain has catalytic function; the other domains are assumed to mediate interactions with TOR substrates and regulators. Except for the rapamycin-binding domain, there are no high-resolution structural data available for TOR. Here, we present a structural, biophysical, and mutagenesis study of the extremely conserved COOH-terminal FATC domain. The importance of this domain for TOR function has been highlighted in several publications. We show that the FATC domain, in its oxidized form, exhibits a novel structural motif consisting of an ␣-helix and a COOHterminal disulfide-bonded loop between two completely conserved cysteine residues. Upon reduction, the flexibility of the loop region increases dramatically. The structural data, the redox potential of the disulfide bridge, and the biochemical data of a cysteine to serine mutant indicate that the intracellular redox potential can affect the cellular amount of the TOR protein via the FATC domain. Because the amount of TOR mRNA is not changed, the redox state of the FATC disulfide bond is probably influencing the degradation of TOR.
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Regulation of cellular growth is a prerequisite for cells, organs, and organisms to achieve a characteristic size. The target of rapamycin (TOR, 1 also known as FRAP, RAFT, RAPT, or SEPT) is a highly conserved 280-kDa Ser/Thr kinase that has been shown to play a central role in the control of cell growth in organisms ranging from yeast to human (1, 2) . TOR proteins consist of several functional domains (see Fig. 1a ) (3) . The amino-terminal ϳ1200 residues consist of stretches of HEAT (huntingtin, elongation factor 3, regulatory subunit A of PP2A, TOR1) repeats, which typically mediate protein-protein interactions. Recently, it was also suggested that the ϳ550-amino acid-long FAT (FRAP, ATM, TTRAP) domain that follows the HEAT repeats is composed of HEAT repeat-like ␣-helical structures and could also serve as a protein interaction platform (4) . The known interactions of TOR with other proteins have been reviewed recently (1, 2) . The FKBP12-rapamycin binding site is flanked by the FAT domain and the catalytic kinase domain. Binding of the FKBP12⅐rapamycin complex to the FKBP12-rapamycin-binding domain specifically inhibits TOR (5) . The catalytic kinase domain is highly homologous to that of phosphatidylinositol 3-and 4-kinases. Thus, TOR and its relatives have been termed phosphatidylinositol kinase-related kinases. TOR has been shown to fulfill its functions by directly phosphorylating serine and threonine residues of target proteins and by regulating protein phosphatases (1, 2) . The carboxylterminal ϳ33 residues of TOR form the FATC domain. In all phosphatidylinositol kinase-related kinases, the FATC domain always occurs in tandem with the FAT domain (6) . Previous studies have shown that the FATC domain is indispensable for TOR function in vivo and in vitro (7, 8) .
Here, we report the solution structure of y1fatc, the FATC domain of yeast TOR1 (residues 2438 -2470), which showed a new structural motif consisting of an ␣-helix and a disulfidebonded loop. Reduction of the disulfide bond resulted in strong conformational changes and increased flexibility of the loop region. The structural data, together with the determined intermediate range redox potential (Ϫ0.23 V) and the biochemical characterization of a Cys to Ser mutant of the full-length protein, suggest that the cellular stability of TOR toward degradation and possibly its function can be redox-regulated.
EXPERIMENTAL PROCEDURES
Protein Expression-Constructs of the yeast TOR1 FATC (y1fatc) domain were designed based on sequence conservation. Residues 2438 -2470 were cloned into GEV2 (9) using the BamHI and XhoI sites and overexpressed in Escherichia coli Rosetta (DE3) (Novagen) in M9 minimal medium. About 40% of the IgG-y1fatc fusion protein was in the soluble fraction obtained after sonication of the cells in 50 mM Tris-HCl, 2 mM EDTA, 2 mM benzamidine, pH 7.5. The remaining 60% of the protein was extracted from inclusion bodies. Inclusion bodies were washed with 20 mM Tris-HCl, 1 M urea, pH 7.5, and extracted using 50 mM Tris-HCl, 6 M guanidinium hydrochloride, pH 7.5, with agitation for 1 h at 4°C. The extract was dialyzed to TST buffer (50 mM Tris buffer, pH 7.6, 150 mM NaCl, 0.05% Tween 20; equilibration buffer for the * This work was supported in part by the Canton of Basel and Swiss National Science Foundation Grant 31-61 757.00 (to S. G. and M. N. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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IgG-Sepharose, see below). IgG-y1fatc fusion protein was extracted from the cleared lysate and from the dialyzed inclusion body extract using an IgG-Sepharose 6 fast flow column (Amersham Biosciences) as described in the manufacturer's manual. The purified fusion protein was lyophilized, resuspended in 50 mM Tris, 100 mM NaCl, pH 8, and desalted using a PD-10 column (Amersham Biosciences). The protein was eluted with 50 mM Tris-HCl, 100 mM NaCl, pH 8, and, after the addition of 2 mM CaCl 2 , digested with Factor Xa (Amersham Biosciences) overnight. After digestion, the fusion partner was removed by reversed-phase high pressure liquid chromatography in an acetonitrile/ trifluoroacetic acid buffer system, and fractions containing pure y1fatc were lyophilized. Electrospray mass spectrometry confirmed that y1fatc had the correct molecular weight. Analytical ultracentrifugation experiments of air oxidized y1fatc in 50 mM Tris, pH 7, showed that y1fatc was monomeric.
NMR Sample Preparation-Lyophilized 15 N-or 15 N, 13 C-labeled y1fatc was dissolved in 10 mM Tris, pH 8 (in 95% H 2 O/5% D 2 O or in 100% D 2 O), and the pH was adjusted to 6. Reduced samples were obtained by adding 20 mM Tris(2-carboxylethyl)phosphine-HCl. The sample for measuring residual dipolar couplings contained about 25 mg/ml PF1 phages (ASLA Biotech). The protein concentration was always ϳ0.5 mM.
NMR Spectroscopy-NMR spectra were acquired at 298 K on Bruker DRX600 and 800 spectrometers. The data were processed with NMRPipe (10) and analyzed using NMRView (11) . Assignments for 13 (16) . Stereospecific assignments were obtained for 14 ␤-methylene proton pairs. Based on 3 J H␣H␤2/3 coupling constants and NOE/ROE data, side chain 1 angles were restrained to one of the staggered conformations (60°, 180°, Ϫ60°) Ϯ 30°. N-H residual dipolar couplings were included using the SANI statement and an error bound of 0.2 Hz. The distance between the C␣ atoms of the disulfide bondforming cysteines was restrained to be within 4.2-7.0 Å and the dihedral angle around the disulfide bond to be 0°Ϯ 105°, because the dihedral angle 3 is always 95°or Ϫ95°Ϯ 10° (17) .
Determination of the Redox Potential-The redox potential of y1fatc was determined by following the protein fluorescence at 350 nm for different ratios of reduced and oxidized glutathione ([GSH] 2 /[GSSG]) and analyzing the data as described previously (18) . Samples contained 1.1 M y1fatc in 10 mM Tris-HCl, pH 7, 0.1 mM EDTA, 0.1 mM GSSG, and concentrations of GSH ranging from 10 M to 90 mM. All buffers were degassed and flushed with argon. The concentration of reduced glutathione in the buffer was verified with an Ellman assay (19) . All samples were prepared under nitrogen atmosphere. All measurements were performed at 25°C (298 K) on an Aminco Bowman series 2 luminescence spectrometer using 1 ϫ 1-cm quartz cuvettes (right angle arrangement), an excitation wavelength of 280 nm, and a bandwidth of 4 nm. The bandwidth for detection was 8 nm.
Mutagenesis Studies-Plasmid pJM244 (pTOR2 C3 S ) was constructed by PCR amplification of a 1300-bp fragment of the COOHterminal region of yeast TOR2 using the primers TOR2D (5Ј-GGT AAA CAG TTG CCA CAA TTA CAA TTA CAA ACT CTT GAA CTA CAA CAT GTG TCG CC) and TOR2Rmut (5Ј-GAA CTC GAG TAC AAC TAA GTG ATT TTC AAT ACA TTA AAA CTA CCA GAA TGG AGA CC) containing an artificial XhoI restriction site and a single base change (underlined) compared with the TOR2 wild-type sequence resulting in the C2470S mutation. The resulting PCR fragment was digested with SpeI and XhoI and used to substitute the SpeI-XhoI fragment of plasmid p206 (20) , a yeast centromeric plasmid containing an NH 2 -terminal hemagglutinin epitope-tagged TOR2 expressed under the control of its own promoter. Plasmid pJM232 (pTOR2) was constructed in a similar way, but with primer TOR2Rnat as TOR2Rmut and with a C instead of the underlined G, to amplify the wild-type sequence. As a control, the same centromeric plasmid without the TOR2 sequence (pRS314 ϭ pVector) was used. No additional mutations were introduced in plasmids pJM232 and pJM244 as confirmed by sequencing of the SpeI-XhoI fragment. These plasmids were used to transform the Saccharomyces cerevisiae strains SH121 and SH221 (21) . Yeast strains were grown in rich medium (yeast extract/peptone/dextrose) or synthetic minimal medium complemented with the appropriate nutrients for plasmid maintenance as described previously (22) . Paromomycin and rapamycin were added at the indicated concentration from a concentrated stock to autoclaved yeast extract/peptone/dextrose with 2% agar prior to gelation. Spot tests of yeast growth were performed as described previously (23) , but plates were incubated at a restrictive temperature (37°C) for the thermosensitive allele of TOR2. Immunoprecipitation assays were performed as described previously (24) .
RESULTS
The FATC Structure-The FATC domain of the family of TOR kinases is highly conserved. Fig. 1b shows an alignment of the carboxyl-terminal 33 residues of TOR proteins from different species. One-third of the residues are completely conserved, including two cysteines in an i to i ϩ 7 spacing. To elucidate the role of the two cysteines for the structure of the FATC domain, we first acquired 15 N-HSQC spectra of oxidized and reduced y1fatc (Fig. 2) . Oxidized y1fatc shows a spectrum characteristic for a folded protein with well dispersed amide proton nitrogen cross-peaks for the majority of residues. In the spectrum of the reduced form, resonances for the carboxyl-terminal 15 residues (2456 -2470) were broadened beyond detection, indicating increased conformational flexibility because of the reduction of the disulfide bond in this region. To understand the molecular basis of the differences between the oxidized and the reduced forms, we have determined the structure of the oxidized form using standard NMR techniques.
The NMR structure of oxidized y1fatc is shown in Fig. 3 , and structural statistics are given in Table I . The structure consists of a long, NH 2 -terminal ␣-helix extending from residue Glu 2444 to the first cysteine, Cys 2460 (Fig. 3, a and b) , and a COOHterminal disulfide-bonded loop from Cys 2460 to Cys 2467 that folds the protein chain back onto itself. This chain reversal is facilitated by the completely conserved glycine at position 2465. Contacts within the loop are dominated by interactions involving aromatic side chains (Fig. 3d) 15 N T 2 values. However, the effect of even very pronounced asymmetry of the diffusion tensor would be too small to account for the observed shortening of t 2 . A more extended analysis using the program TENSOR (26) and an isotropic model as a first approximation for the rotational diffusion of y1fatc showed that the chemical exchange contributions (R ex ) increase strongly from the beginning to the end of the structured part (Fig. 4, bottom panel) . The subnanosecond order parameter S 2 also increases from values around 0.3 at the NH 2 terminus to values around 0.8 at the COOH terminus (Fig. 4, fourth panel) . Thus on the subnanosecond time scale, there are large amplitude motions at the NH 2 terminus but only small amplitude motions at the COOH-terminal end of the structure. In contrast, micro-to millisecond time scale motions are stronger in the COOH-terminal half. Therefore, albeit folded, the helix and loop parts of the FATC structure are partly flexible, with the time scale of motions becoming longer toward the COOH terminus. This observation is not surprising because the FATC domain is stabilized by only a few tertiary contacts at the COOH-terminal end that are mediated by the disulfide bridge.
The 13 C ␣ and 1 H ␣ resonances of Cys 2467 are not visible in the NMR spectra of y1fatc, and its side chain and the one following residue Pro 2468 show only few and broad NOE contacts. Presumably, this is because of additional conformational exchange from disulfide bond crankshaft motions like the ones that have been characterized in bovine pancreatic trypsin inhibitor (27) . Indeed, in the structure calculations, the left-hand conformation (17) of the disulfide bond is only slightly more favored (13 of the 20 best structures) than the right-hand conformation.
A second minor set of resonances was observed for the backbone amides of residues Phe 2469 and Trp 2470 (Fig. 2) and for the Pro 2468 C␦/H␦ nuclei in the 13 C-HSQC spectrum. These resonances indicate the presence of a minor cis-form of Pro 2468 in addition to the predominant trans-form. As judged from the spectral intensities, this cis-form is populated to 15-20%. Very similar structures for the rest of FATC were obtained when Pro 2468 was constrained to the cis-instead of the trans-conformation (data not shown).
Determination of the Redox Potential-Because both tryptophans of y1fatc are in the vicinity of the disulfide bond-forming cysteines (Fig. 3d) , the redox state-dependent fluorescence at 350 nm was used to determine the redox potential (18) of the Cys 2460 -Cys 2467 disulfide bond of y1fatc. For y1fatc equilibrated in buffers containing different ratios of oxidized and reduced glutathione, we detected a two-state transition curve (Fig. 5a ) that corresponds to an equilibrium constant (K eq ) of 0.45 M. Using the Nernst equation EЈ 0 y1fatc ϭ EЈ 0 GSH/GSSG Ϫ (RT/2F) ln K eq , with EЈ 0 GSH/GSSG ϭ Ϫ0.24 V, this results in a redox potential of Ϫ0.23 V for y1fatc. Apparently, this value is very close to the one for glutathione. Other cellular components (Fig. 5b) are more reducing or more oxidizing than y1fatc, such as thioredoxin (Ϫ0.27 V) or cytochrome c (0.22 mV), respectively.
Mutagenesis Studies-In yeast, two highly homologous TOR proteins have been identified. TOR1 is only found as part of TOR⅐C1 (complex 1), a multiprotein complex that regulates cell growth in a rapamycin-sensitive manner. In contrast, TOR2 can be found as part of TOR⅐C1 but additionally can participate in a second protein complex called TOR⅐C2. The known function of the complex TOR⅐C2 is to regulate the polarization of the actin cytoskeleton in a rapamycin-insensitive manner (24) . To study the influence of the FATC disulfide bonds on both complexes, mutagenesis studies were carried out on the TOR2 protein.
In detail, the second of the disulfide bond-forming cysteines in TOR2 (Cys 2470 ϭ Cys 2467 in TOR1) was changed to serine (C2470S). To investigate the effect of this TOR2 mutation on the function of the rapamycin-insensitive complex TOR⅐C2, a plasmid containing the C2470S mutation (pTOR2 C3 S ) was introduced into the yeast strain SH121 (21) that carries a thermosensitive allele of TOR2. The pTOR2 C3 S plasmid was able to complement the thermosensitive phenotype under restrictive temperature conditions (37°C), where expression of wild-type TOR2 protein is suppressed (data not shown). Experiments with an isogenic wild-type plasmid (pTOR2) yielded identical results. Thus, the function of complex TOR⅐C2 is not affected by the C2470S mutation.
To investigate the effect of the C2470S mutation on the function of the rapamycin-sensitive complex TOR⅐C1, the pTOR2 C3 S plasmid was introduced into the yeast strain SH221 that is deleted in TOR1 and carries a thermosensitive allele of TOR2 (21) . Switching from the permissive (30°C) to the restrictive temperature (37°C) under normal or stressful conditions, including oxidative or osmotic stress, did not lead to a growth defect (data not shown). However, at the restrictive temperature, the strain carrying plasmid pTOR2 C3 S was unable to grow on medium containing sublethal concentrations of paromomycin, a protein synthesis inhibitor, or of rapamycin, a TOR-C1-specific inhibitor (Fig. 6a) . In contrast, controls at the permissive temperature or on the same strain transformed with the plasmid pTOR2 showed normal growth (Fig. 6a) . Thus the C2470S mutation affects the activity of the rapamycinsensitive complex TOR⅐C1 in the presence of paromomycin or rapamycin.
This effect on the activity could be caused by a structural change within the complex or by a general destabilization of TOR2 that leads to smaller cellular concentrations. To investigate this effect further, we performed an immunoprecipitation of TOR2 extracted from yeast cells that were grown identically at the restrictive temperature (37°C) and that were expressing either wild-type or mutated TOR2. The amount of C2470S TOR2 was ϳ3-fold less than that of wild-type TOR2 (Fig. 6b) . Thus, the C2470S mutation reduces the amount of TOR2 protein, which may explain the paromomycin-and rapamycin-hypersensitive phenotypes described above. To make sure that the mutation does not simply affect the amount of TOR2 on the mRNA level, we performed reverse transcription-PCR experiments (data not shown) using the same strains, genetic constructs, and growth conditions as for the immunoprecipitation. These experiments showed that the mutation does not change either the transcription or, presumably, the expression level of TOR2 (data not shown). We also performed immunofluorescence experiments on whole fixed cells to determine the cellular location of the mutant TOR2, but no changes in localization compared with wild-type TOR2 were detected (data not shown).
DISCUSSION
In the present study, we investigated the structure of the highly conserved yeast TOR1 FATC domain. In its oxidized form, FATC consists of an ␣-helix and a well structured disulfide-bonded loop between two completely conserved cysteines (Cys 2460 and Cys 2467 ). The NH 2 -terminal half of the helix and the loop region next to the COOH terminus are rather acidic (Fig. 3c) , whereas the remaining part of the loop is more hydrophobic. Therefore, oxidized FATC could bind to a hydrophobic surface of complementary shape surrounded by polar residues. Reduction of the disulfide bond dramatically increases the flexibility within the COOH-terminal loop region and presumably the accessibility of several hydrophobic side chains in this region. Thus the reduction may alter the binding behavior of FATC to other parts of TOR or other cellular partners.
The redox potential of the Cys 2460 -Cys 2467 disulfide bridge was determined as Ϫ0.23 V. This value is very similar to the one for glutathione (Fig. 5b) . In yeast, a C2470S TOR2 mutation had no significant effect on growth under normal or stressful conditions. However, cells carrying the TOR2 C2470S mutation were hypersensitive to rapamycin and paromomycin. This observation, together with the fact that TOR2 carrying the C2470S mutation is less abundant than wild-type TOR2, indicates that the cellular amount of TOR is affected by the redox state of the FATC domain. Because the level of TOR mRNA is not changed, the redox state of the FATC disulfide bond is probably influencing the degradation of TOR.
Commonly, the cytosol is considered to be a reducing envi- C3 S is unable to grow in the presence of rapamycin or paromomycin. Precultures of the indicated strains were grown in selective synthetic minimal media until saturation. Water dilutions of each strain (1/10, 1/100, and 1/1000) were spotted on yeast extract/ peptone/dextrose medium containing the indicated concentration of rapamycin or paromomycin, and growth was recorded after 4 days. Identical results were obtained from at least six independent colonies of each strain in two separate experiments. b, TOR2 C3 S protein is less abundant than TOR2 protein. Cells expressing hemagglutinin-TOR2 (wild type (wt)) and hemagglutinin-TOR2 C3 S (C3 S) were grown (at 37°C) and harvested, and the protein was extracted in the same way. The protein concentration was determined by a Bradford assay. Both cell lysates were subjected to immunoprecipitation with anti-hemagglutinin, and the resulting precipitates were resolved by SDS-PAGE and Western blotted to detect TOR2. As a control, actin was immunoprecipitated in parallel (bottom panel).
ronment. Very few values of the redox potential in living cells have been reported. The determination of appropriate values is hampered because the intracellular redox potential may depend on the location, metabolic state, differentiation, and type of the cell. The redox potential for the overall intracellular environment of a mammalian cell line was determined to range from Ϫ0.221 to Ϫ0.236 V (28). Using a green fluorescent protein with an engineered disulfide bond (rxYFP), the redox potential of the cytosolic glutathione pool of wild-type yeast cells under normal growth conditions was determined to be Ϫ0.289 V but changed to Ϫ0.227 V upon mutation of genes involved in the regulation of the cytosolic glutathione pool (29) . During the life cycle of mammalian cells, the cytosolic redox potential was found to range between ϳϪ0.260 and Ϫ0.160 V (30). In proliferating mammalian cells, the redox potential is ϳϪ0.24 V (28, 31, 32), whereas more oxidizing conditions are found in differentiating cells (ϳϪ0.2 V) (30) and at the onset of apoptosis (ϳϪ0.17 to Ϫ0.19 V) (31, 32) . TOR has also been found in the nucleus (33) . However, to our knowledge, no information is available on the redox potential within the nucleus.
Based on the reported cellular redox potentials, it is possible that TOR exists in both reduced and oxidized forms in the cellular environment. The ratio of oxidized to reduced TOR during the cellular life cycle could be altered through the action of typical cellular redox regulators (glutathione, thioredoxin, glutathione S-transferase, cytochrome c, reactive oxygen species, etc.), in which concentrations depend on metabolic activities in response to the availability of nutrients, the action of growth hormones, and the influence of stress (oxidative, UV, etc.). Furthermore, the local redox potential for the FATC disulfide bond may be modulated within the various TOR complexes.
Several examples exist of cytosolic and nuclear proteins that are regulated through the reversible oxidation of a cysteine side chain. The roles of redox-sensitive proteins involved in stress responses (34) , regulation of cell death (35) , and cancer proliferation (36) have been reviewed recently. Within the TOR signaling cascade, various redox-dependent proteins or processes have been reported. For example, the lipid phosphatase PTEN, a tumor suppressor, is redox-regulated. Mutations or loss of PTEN are associated with an increased activation of mTOR (37, 38) . PTEN is inactivated through the reversible formation of a disulfide bond in its active site (39) . Furthermore, it has been suggested that mTOR is involved in the regulation of hypoxia-inducible factor 1␣ (40 -43) and that hypoxia can trigger hypophosphorylation of mTOR and some of its effectors in a hypoxia-inducible factor-independent manner (41) . Obviously low oxygen pressure (hypoxia) should influence the redox potential within the cell. Additionally, it has been suggested that the UV response pathway induces the phosphorylation of p70 S6 kinase in an mTOR-dependent manner via the generation of reactive oxygen species (44) . Finally, TOR can associate with the mitochondrial outer membrane (45) , which could make it directly susceptible to (redox) signals from this organelle.
The effect of mutations within the mTOR FATC domain has been investigated in two studies (7, 8) . Both show that deletion of the carboxyl-terminal tryptophan as well as small deletions (three or more residues) of the COOH terminus abolish mTOR autophosphorylation activity as well as mTOR-dependent phosphorylation of eukaryotic initiation factor 4E-binding protein and p70 S6 kinase. Thus, the COOH-terminal deletions abolished mTOR function. These findings indicate that the FATC domain interacts with other parts of TOR or other components of TOR complexes (24, 46 -49) to activate kinase function. Notably, a C2546A mutation in the FATC domain of mTOR did not prevent mTOR from autophosphorylating or activating p70 S6 kinase (7) . Nevertheless, from the autoradiogram presented, it can be concluded that the degree of p70 S6 kinase activation was lower for mutated than for wild-type mTOR. In agreement with these data, our C2470S yeast TOR2 mutant is also still active, but its cellular concentration is lowered.
In conclusion, we have presented the structure of the FATC domain of yeast TOR1. FATC forms a novel structural motif consisting of an ␣-helix and a COOH-terminal disulfide-bonded loop. Upon reduction of this disulfide bond, the flexibility of FATC increases dramatically. Considering that several redoxdependent processes can be connected to the TOR signaling cascade, it seems attractive to propose that the function of TOR can be redox-regulated via the highly conserved FATC disulfide bond. Our data indicate that the redox potential of the disulfide bond is in an intermediate range and that the cellular amount of TOR is affected by the C2470S mutation. An analogous redox-regulatory mechanism for the cellular stability of a protein has been suggested for the phosphatase Cdc25C, which is involved in the regulation of cell cycle progression (50) . Future biochemical and structural experiments will be required to shed light on the influence of changes in the cytosolic redox potential on the FATC domain and its interactions with other TOR domains or components of TOR complexes.
